Therapy: The risk of herpes zoster: another cost of anti-TNF therapy?
Bongartz
Tim
T
Orenstein
Robert
R
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy*; D006562:Herpes Zoster / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D016867:Immunocompromised Host; D018570:Risk Assessment; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014481:United States / Q000453:epidemiology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha